Wed, Apr 16, 2014, 4:41 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Cytokinetics, Incorporated Message Board

  • shorernd shorernd Jan 9, 2013 1:50 PM Flag

    Hate to post this on an uptick but I wanted to share analyst consensus and thoughts

    Nothing has materially changed since I bought in last month but it has picked up steam for two reasons:
    1 -NY times article highlighting Biogen dropping ALS program and CYTK, is one of two other companies developing.
    2- Piper initiated coverage and a $4.00 PT made me pull up the consensus as of today..
    Lazard - $3, Needham $2.50, Canacord, JMP, and MLV all $4.00 and Dawson $2.00. no one that I know that covers has a Hold or Sell. Tirasemtiv is a long way off but on a risk reward basis, $1 is good enough for me.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
CYTK
9.07+0.22(+2.49%)4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.